Promising combo may slash radiation harm in rare lymphoma

This study tests whether adding the drug selinexor to a lower dose of radiation can treat early-stage NK/T-cell lymphoma just as well as standard high-dose radiation, but with fewer side effects. About 34 people who have not had prior treatment will receive chemotherapy first, then selinexor plus 40 Gy radiation. The goal is to see if this approach keeps the cancer under control while reducing mouth sores and dry mouth.